Pro Dex Stock Net Income
| PDEX Stock | USD 38.87 1.55 3.83% |
As of the 23rd of January, Pro Dex holds the Semi Deviation of 3.06, risk adjusted performance of 0.1368, and Coefficient Of Variation of 574.39. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pro Dex, as well as the relationship between them.
Pro Dex Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.9268 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 10.3 M | 10.8 M | |
| Net Income Applicable To Common Shares | 8.1 M | 8.5 M | |
| Net Income From Continuing Ops | 10.3 M | 10.8 M | |
| Net Income Per Share | 2.46 | 2.58 | |
| Net Income Per E B T | 0.67 | 0.63 |
Pro | Net Income | Build AI portfolio with Pro Stock |
Latest Pro Dex's Net Income Growth Pattern
Below is the plot of the Net Income of Pro Dex over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Pro Dex financial statement analysis. It represents the amount of money remaining after all of Pro Dex operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Pro Dex's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pro Dex's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 8.98 M | 10 Years Trend |
|
Net Income |
| Timeline |
Pro Net Income Regression Statistics
| Arithmetic Mean | 3,668,390 | |
| Coefficient Of Variation | 110.00 | |
| Mean Deviation | 3,375,309 | |
| Median | 4,148,000 | |
| Standard Deviation | 4,035,201 | |
| Sample Variance | 16.3T | |
| Range | 12.6M | |
| R-Value | 0.89 | |
| Mean Square Error | 3.6T | |
| R-Squared | 0.79 | |
| Slope | 711,893 | |
| Total Sum of Squares | 260.5T |
Pro Net Income History
Other Fundumenentals of Pro Dex
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Pro Dex Net Income component correlations
Pro Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Pro Dex is extremely important. It helps to project a fair market value of Pro Stock properly, considering its historical fundamentals such as Net Income. Since Pro Dex's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pro Dex's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pro Dex's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pro Dex. If investors know Pro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pro Dex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.867 | Earnings Share 3.32 | Revenue Per Share | Quarterly Revenue Growth 0.244 | Return On Assets |
The market value of Pro Dex is measured differently than its book value, which is the value of Pro that is recorded on the company's balance sheet. Investors also form their own opinion of Pro Dex's value that differs from its market value or its book value, called intrinsic value, which is Pro Dex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pro Dex's market value can be influenced by many factors that don't directly affect Pro Dex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pro Dex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pro Dex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pro Dex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Pro Dex 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pro Dex's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pro Dex.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Pro Dex on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Pro Dex or generate 0.0% return on investment in Pro Dex over 90 days. Pro Dex is related to or competes with Sharps Technology, Sera Prognostics, Microbot Medical, Lucid Diagnostics, Cognition Therapeutics, Apyx Medical, and Greenwich Lifesciences. Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipm... More
Pro Dex Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pro Dex's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pro Dex upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.34 | |||
| Information Ratio | 0.1498 | |||
| Maximum Drawdown | 26.61 | |||
| Value At Risk | (5.08) | |||
| Potential Upside | 6.97 |
Pro Dex Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pro Dex's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pro Dex's standard deviation. In reality, there are many statistical measures that can use Pro Dex historical prices to predict the future Pro Dex's volatility.| Risk Adjusted Performance | 0.1368 | |||
| Jensen Alpha | 0.5997 | |||
| Total Risk Alpha | 0.1901 | |||
| Sortino Ratio | 0.1919 | |||
| Treynor Ratio | 0.5109 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pro Dex's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pro Dex January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1368 | |||
| Market Risk Adjusted Performance | 0.5209 | |||
| Mean Deviation | 3.04 | |||
| Semi Deviation | 3.06 | |||
| Downside Deviation | 3.34 | |||
| Coefficient Of Variation | 574.39 | |||
| Standard Deviation | 4.28 | |||
| Variance | 18.31 | |||
| Information Ratio | 0.1498 | |||
| Jensen Alpha | 0.5997 | |||
| Total Risk Alpha | 0.1901 | |||
| Sortino Ratio | 0.1919 | |||
| Treynor Ratio | 0.5109 | |||
| Maximum Drawdown | 26.61 | |||
| Value At Risk | (5.08) | |||
| Potential Upside | 6.97 | |||
| Downside Variance | 11.15 | |||
| Semi Variance | 9.36 | |||
| Expected Short fall | (3.60) | |||
| Skewness | 1.16 | |||
| Kurtosis | 3.67 |
Pro Dex Backtested Returns
Pro Dex appears to be very steady, given 3 months investment horizon. Pro Dex maintains Sharpe Ratio (i.e., Efficiency) of 0.13, which implies the firm had a 0.13 % return per unit of risk over the last 3 months. By analyzing Pro Dex's technical indicators, you can evaluate if the expected return of 0.59% is justified by implied risk. Please evaluate Pro Dex's Coefficient Of Variation of 574.39, semi deviation of 3.06, and Risk Adjusted Performance of 0.1368 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pro Dex holds a performance score of 10. The company holds a Beta of 1.44, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pro Dex will likely underperform. Please check Pro Dex's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Pro Dex's historical price patterns will revert.
Auto-correlation | 0.11 |
Insignificant predictability
Pro Dex has insignificant predictability. Overlapping area represents the amount of predictability between Pro Dex time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pro Dex price movement. The serial correlation of 0.11 indicates that less than 11.0% of current Pro Dex price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.11 | |
| Spearman Rank Test | -0.57 | |
| Residual Average | 0.0 | |
| Price Variance | 3.16 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Pro Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Pro Dex reported net income of 8.98 M. This is 97.37% lower than that of the Health Care Equipment & Supplies sector and 90.99% lower than that of the Health Care industry. The net income for all United States stocks is 98.43% higher than that of the company.
Pro Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pro Dex's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pro Dex could also be used in its relative valuation, which is a method of valuing Pro Dex by comparing valuation metrics of similar companies.Pro Dex is currently under evaluation in net income category among its peers.
Pro Dex Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pro Dex from analyzing Pro Dex's financial statements. These drivers represent accounts that assess Pro Dex's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pro Dex's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 58.0M | 68.2M | 64.2M | 143.5M | 129.1M | 135.6M | |
| Enterprise Value | 73.1M | 80.1M | 75.1M | 159.6M | 143.7M | 150.9M |
Pro Dex ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pro Dex's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pro Dex's managers, analysts, and investors.Environmental | Governance | Social |
Pro Dex Institutional Holders
Institutional Holdings refers to the ownership stake in Pro Dex that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Pro Dex's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pro Dex's value.| Shares | Citadel Advisors Llc | 2025-06-30 | 11.5 K | Renaissance Technologies Corp | 2025-06-30 | 11.2 K | Bank Of New York Mellon Corp | 2025-06-30 | 11 K | Bard Associates Inc | 2025-06-30 | 10.6 K | Davidson D A & Co | 2025-06-30 | 10.3 K | American Century Companies Inc | 2025-06-30 | 10.2 K | Ubs Group Ag | 2025-06-30 | 7.9 K | Charles Schwab Investment Management Inc | 2025-06-30 | 7.2 K | Advisor Group Holdings, Inc. | 2025-06-30 | 7.1 K | Blackrock Inc | 2025-06-30 | 149.7 K | Vanguard Group Inc | 2025-06-30 | 146.2 K |
Pro Fundamentals
| Return On Equity | 0.31 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 135.32 M | ||||
| Shares Outstanding | 3.26 M | ||||
| Shares Owned By Insiders | 36.02 % | ||||
| Shares Owned By Institutions | 32.38 % | ||||
| Number Of Shares Shorted | 205.9 K | ||||
| Price To Earning | 13.30 X | ||||
| Price To Book | 3.18 X | ||||
| Price To Sales | 1.89 X | ||||
| Revenue | 66.59 M | ||||
| Gross Profit | 19.73 M | ||||
| EBITDA | 14.13 M | ||||
| Net Income | 8.98 M | ||||
| Cash And Equivalents | 1.6 M | ||||
| Cash Per Share | 0.44 X | ||||
| Total Debt | 16.58 M | ||||
| Debt To Equity | 0.67 % | ||||
| Current Ratio | 2.74 X | ||||
| Book Value Per Share | 12.73 X | ||||
| Cash Flow From Operations | (1.68 M) | ||||
| Short Ratio | 6.70 X | ||||
| Earnings Per Share | 3.32 X | ||||
| Target Price | 56.0 | ||||
| Number Of Employees | 179 | ||||
| Beta | -0.048 | ||||
| Market Capitalization | 132.58 M | ||||
| Total Asset | 61.19 M | ||||
| Retained Earnings | 35.93 M | ||||
| Working Capital | 32.67 M | ||||
| Current Asset | 9.22 M | ||||
| Current Liabilities | 2.16 M | ||||
| Net Asset | 61.19 M |
About Pro Dex Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pro Dex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pro Dex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pro Dex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pro Stock Analysis
When running Pro Dex's price analysis, check to measure Pro Dex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pro Dex is operating at the current time. Most of Pro Dex's value examination focuses on studying past and present price action to predict the probability of Pro Dex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pro Dex's price. Additionally, you may evaluate how the addition of Pro Dex to your portfolios can decrease your overall portfolio volatility.